Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Gotch

Showing results (61-70 of 91) with videos related to

Pageof 10
Sort By:
Immunology Today|June 4, 1999
Immune correlates of protection from HIV and AIDS - more answers but yet more questionsJ L Heeney, P Beverley, A McMichael, et al.
AIDS (London, England)|October 2, 2001
A point mutation in CD45 may be associated with an increased risk of HIV-1 infectionE Z Tchilian, D L Wallace, R Dawes, et al.
HIV Medicine|December 12, 2001
Molecular correlates in AIDS patients following antiretroviral therapy: diversified T-cell receptor repertoires and in vivo control of cytomegalovirus replicationS Worrell, J Deayton, P Hayes, et al.
Experimental and Clinical Immunogenetics|March 24, 1999
HLA-A, -B, -C, -DRB1, DRB3, DRB4, DRB5 and DQB1 polymorphism detected by PCR-SSP in a semi-urban HIV-positive Ugandan populationP Krausa, S McAdam, M Bunce, et al.
Clinical and Experimental Immunology|November 25, 2003
A pilot study of the safety and efficacy of thymosin alpha 1 in augmenting immune reconstitution in HIV-infected patients with low CD4 counts taking highly active antiretroviral therapyD Chadwick, J Pido-Lopez, A Pires, et al.
HIV Medicine|June 13, 2002
Thymic activity in late-stage HIV-1 infected individuals receiving highly active antiretroviral therapy: potential effect of steroid therapyJ Pido-Lopez, A Pires, M Nelson, et al.
Vaccine|June 1, 1995
Immunogenicity of the yeast recombinant p17/p24:Ty virus-like particles (p24-VLP) in healthy volunteersJ Weber, R Cheinsong-Popov, D Callow, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|June 12, 1989
Recognition of influenza virus proteins by cytotoxic T lymphocytesA Townsend, J Bastin, H Bodmer, et al.
AIDS (London, England)|May 16, 1998
Cross-clade recognition of p55 by cytotoxic T lymphocytes in HIV-1 infectionS McAdam, P Kaleebu, P Krausa, et al.
Journal of Virology|June 11, 1999
Identification of human herpesvirus 8-specific cytotoxic T-cell responsesM Osman, T Kubo, J Gill, et al.
Pageof 10

Showing results (61-70 of 91) with videos related to

Sort By:
Pageof 10
Immunology Today|June 4, 1999
Immune correlates of protection from HIV and AIDS - more answers but yet more questionsJ L Heeney, P Beverley, A McMichael, et al.
AIDS (London, England)|October 2, 2001
A point mutation in CD45 may be associated with an increased risk of HIV-1 infectionE Z Tchilian, D L Wallace, R Dawes, et al.
HIV Medicine|December 12, 2001
Molecular correlates in AIDS patients following antiretroviral therapy: diversified T-cell receptor repertoires and in vivo control of cytomegalovirus replicationS Worrell, J Deayton, P Hayes, et al.
Experimental and Clinical Immunogenetics|March 24, 1999
HLA-A, -B, -C, -DRB1, DRB3, DRB4, DRB5 and DQB1 polymorphism detected by PCR-SSP in a semi-urban HIV-positive Ugandan populationP Krausa, S McAdam, M Bunce, et al.
Clinical and Experimental Immunology|November 25, 2003
A pilot study of the safety and efficacy of thymosin alpha 1 in augmenting immune reconstitution in HIV-infected patients with low CD4 counts taking highly active antiretroviral therapyD Chadwick, J Pido-Lopez, A Pires, et al.
HIV Medicine|June 13, 2002
Thymic activity in late-stage HIV-1 infected individuals receiving highly active antiretroviral therapy: potential effect of steroid therapyJ Pido-Lopez, A Pires, M Nelson, et al.
Vaccine|June 1, 1995
Immunogenicity of the yeast recombinant p17/p24:Ty virus-like particles (p24-VLP) in healthy volunteersJ Weber, R Cheinsong-Popov, D Callow, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|June 12, 1989
Recognition of influenza virus proteins by cytotoxic T lymphocytesA Townsend, J Bastin, H Bodmer, et al.
AIDS (London, England)|May 16, 1998
Cross-clade recognition of p55 by cytotoxic T lymphocytes in HIV-1 infectionS McAdam, P Kaleebu, P Krausa, et al.
Journal of Virology|June 11, 1999
Identification of human herpesvirus 8-specific cytotoxic T-cell responsesM Osman, T Kubo, J Gill, et al.
Pageof 10